The evaluation of subcutaneous proleukin (interleukin-2) in a randomized international trial: rationale, design, and methods of ESPRIT.
Emery, Sean
The evaluation of subcutaneous proleukin (interleukin-2) in a randomized international trial: rationale, design, and methods of ESPRIT. [electronic resource] - Controlled clinical trials Apr 2002 - 198-220 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0197-2456
10.1016/s0197-2456(01)00179-9 doi
Adult
Anti-HIV Agents--therapeutic use
Clinical Trials, Phase III as Topic--methods
Data Collection--methods
Disease Progression
Drug Therapy, Combination
Female
HIV Infections--drug therapy
Humans
Injections, Subcutaneous
Interleukin-2--therapeutic use
Male
Multicenter Studies as Topic--methods
Patient Selection
Randomized Controlled Trials as Topic--economics
Research Design
Sample Size
Survival Analysis
United States
The evaluation of subcutaneous proleukin (interleukin-2) in a randomized international trial: rationale, design, and methods of ESPRIT. [electronic resource] - Controlled clinical trials Apr 2002 - 198-220 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0197-2456
10.1016/s0197-2456(01)00179-9 doi
Adult
Anti-HIV Agents--therapeutic use
Clinical Trials, Phase III as Topic--methods
Data Collection--methods
Disease Progression
Drug Therapy, Combination
Female
HIV Infections--drug therapy
Humans
Injections, Subcutaneous
Interleukin-2--therapeutic use
Male
Multicenter Studies as Topic--methods
Patient Selection
Randomized Controlled Trials as Topic--economics
Research Design
Sample Size
Survival Analysis
United States